Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1980 1
1985 1
1986 1
1989 1
1990 4
1992 3
1993 2
1995 1
1996 1
1998 2
1999 2
2000 2
2001 2
2002 2
2003 2
2004 3
2005 2
2006 4
2008 1
2009 1
2010 3
2011 4
2012 3
2013 5
2014 2
2015 1
2017 4
2018 4
2019 11
2020 7
2021 17
2022 12
2023 12
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Results by year

Filters applied: . Clear all
Page 1
[Tolosa-Hunt syndrome].
Napoli S, Aguilera C, Villa RA. Napoli S, et al. Medicina (B Aires). 2023;83(6):1034. Medicina (B Aires). 2023. PMID: 38117733 Free article. Spanish. No abstract available.
LncRNAs and Available Databases.
Napoli S. Napoli S. Methods Mol Biol. 2021;2348:3-26. doi: 10.1007/978-1-0716-1581-2_1. Methods Mol Biol. 2021. PMID: 34160796 Review.
Tumor-Associated Microbiome: Where Do We Stand?
Oliva M, Mulet-Margalef N, Ochoa-De-Olza M, Napoli S, Mas J, Laquente B, Alemany L, Duell EJ, Nuciforo P, Moreno V. Oliva M, et al. Among authors: napoli s. Int J Mol Sci. 2021 Feb 1;22(3):1446. doi: 10.3390/ijms22031446. Int J Mol Sci. 2021. PMID: 33535583 Free PMC article. Review.
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial.
Foley JF, Defer G, Ryerson LZ, Cohen JA, Arnold DL, Butzkueven H, Cutter G, Giovannoni G, Killestein J, Wiendl H, Smirnakis K, Xiao S, Kong G, Kuhelj R, Campbell N; NOVA study investigators. Foley JF, et al. Lancet Neurol. 2022 Jul;21(7):608-619. doi: 10.1016/S1474-4422(22)00143-0. Epub 2022 Apr 25. Lancet Neurol. 2022. PMID: 35483387 Clinical Trial.
Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7.
Bandara V, Foeng J, Gundsambuu B, Norton TS, Napoli S, McPeake DJ, Tyllis TS, Rohani-Rad E, Abbott C, Mills SJ, Tan LY, Thompson EJ, Willet VM, Nikitaras VJ, Zheng J, Comerford I, Johnson A, Coombs J, Oehler MK, Ricciardelli C, Cowin AJ, Bonder CS, Jensen M, Sadlon TJ, McColl SR, Barry SC. Bandara V, et al. Among authors: napoli s. Nat Commun. 2023 Sep 8;14(1):5546. doi: 10.1038/s41467-023-41338-y. Nat Commun. 2023. PMID: 37684239 Free PMC article.
Inertial Microfluidic Purification of CAR-T-Cell Products.
Elsemary MT, Maritz MF, Smith LE, Warkiani M, Bandara V, Napoli S, Barry SC, Coombs JT, Thierry B. Elsemary MT, et al. Among authors: napoli s. Adv Biol (Weinh). 2022 Jan;6(1):e2101018. doi: 10.1002/adbi.202101018. Epub 2021 Dec 8. Adv Biol (Weinh). 2022. PMID: 34881810
[Warfarin fetopathy].
Bony C, Zyka F, Tiran-Rajaofera I, Attali T, De Napoli S, Alessandri JL. Bony C, et al. Among authors: de napoli s. Arch Pediatr. 2002 Jul;9(7):705-8. doi: 10.1016/s0929-693x(01)00970-8. Arch Pediatr. 2002. PMID: 12162160 French.
121 results